← Search all jobs

Scientist I - Formulation Development

Astellas (ADP)

South San Francisco, CA · Posted September 9, 2026

Just laid off? Start here: a plan for the first weeks

See every open role at Astellas (ADP)

More in California job market · Healthcare & Hospital Systems · Research jobs

More roles at Astellas (ADP)

Similar jobs

How AI is used in this kind of work

AI use among biochemists and biophysicists is little observed so far. Measured exposure for biochemists and biophysicists: 8% (little observed).

Share of this job’s tasks that AI is already used for at work, from real usage. It is not a forecast of job loss, and a low number means no use seen yet. Source: Anthropic Economic Index.

Check how this applies to your own job

Astellas (ADP) has filed one layoff notice in the last twelve months, covering 50 workers, most recently April 2026. These are public filings with state labor departments, and an open role can sit alongside them. See the filings

About the job

Scientist I (Formulation Development)

Do you want to be part of an inclusive team that works to develop innovative therapies for patients? Every day, we are driven to develop and deliver innovative and effective new medicines to patients and physicians. If you want to be part of this exciting work, you belong at Astellas!

Astellas Pharma Inc. is a pharmaceutical company conducting business in more than 70 countries around the world. We are committed to turning innovative science into medical solutions that bring value and hope to patients and their families. Keeping our focus on addressing unmet medical needs and conducting our business with ethics and integrity enables us to improve the health of people throughout the world. For more information on Astellas, please visit our website at www.astellas.com .

The Role

The primary purposes of the Scientist I, in Formulation & Analytical Development, are to design, evaluate and develop suitable formulations and manufacturing processes for rAAV drug product under development, supporting the growing and diversifying portfolio of programs within AGT’s pipeline.

Responsibilities

Evaluate and understand the properties of new rAAV and propose formulations with sufficient stability during storage and suitability for clinical use.

C onduct in-use stability and delivery device compatibility studies to ensure the quality of drug products during administration at clinical sites.

Author regulatory documents such as IND and briefing documents for meetings with health authorities.; prepare responses to Information Requests from agencies.

Join the technical discussion cross-functional/divisional to align and enable efficient drug development work

Evaluate and understand analytical tools and methods to develop rAAV formulation appropriately .